GENE ONLINE|News &
Opinion
Blog

Biologics
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
Amgen Taps Generate to Discover Multi-Target Protein Drugs in $1.9+ Billion Deal
2022-01-07
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
GenScript’s Biotech Unit, ProBio Bags $150 Million in Series A from Hillhouse Capital
2021-08-20
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top